Search research articles
Contact Us
Filters
Showing results (11-20 of 98) with videos related to
Page
of 10
Sort By:
Parasitology Research
|
March 21, 2006
Schistosoma japonicum and S. mansoni cercariae: different effects of protein in medium, of mechanical stress, and of an intact complement system on in vitro transformation to schistosomula
Wenshi Wang, Michael Kirschfink, Andreas Ruppel
Molecular Immunology
|
June 24, 2018
Complement analysis in the era of targeted therapeutics
Zoltán Prohászka, Michael Kirschfink, Ashley Frazer-Abel
Frontiers in Immunology
|
August 26, 2021
Expanding Horizons in Complement Analysis and Quality Control
Ashley Frazer-Abel, Michael Kirschfink, Zoltán Prohászka
Autoimmunity Reviews
|
June 19, 2008
Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?
Reinhard Schwartz-Albiez, Simon Laban, Stefan Eichmüller, et al.
Arthritis Care & Research
|
October 15, 2011
Remitting fever of unknown origin in a 20-year-old man
Marc Cinci, Michael Kirschfink, Hanns-Martin Lorenz, et al.
Artificial Organs
|
March 25, 2005
Impact of inverse plasma filtration on complement activation in porcine blood
Claudia Haltern, Michael Kirschfink, Rolf Rossaint, et al.
Immunobiology
|
August 1, 2016
Complement analysis 2016: Clinical indications, laboratory diagnostics and quality control
Zoltán Prohászka, Bo Nilsson, Ashley Frazer-Abel, et al.
Fertility and Sterility
|
April 1, 2014
Recurrent miscarriages, innate immunity, and autoimmune reaction to chlamydial 60-kDa heat shock protein--is there an association?
Waltraud Eggert-Kruse, Sandra Scholz, Michael Kirschfink, et al.
Targeted Oncology
|
November 15, 2014
Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack
Marc Cinci, Srinivas Mamidi, Wenhan Li, et al.
Molecular Oncology
|
March 12, 2013
Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab
Srinivas Mamidi, Marc Cinci, Max Hasmann, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 98) with videos related to
Sort By:
Page
of 10
Parasitology Research
|
March 21, 2006
Schistosoma japonicum and S. mansoni cercariae: different effects of protein in medium, of mechanical stress, and of an intact complement system on in vitro transformation to schistosomula
Wenshi Wang, Michael Kirschfink, Andreas Ruppel
Molecular Immunology
|
June 24, 2018
Complement analysis in the era of targeted therapeutics
Zoltán Prohászka, Michael Kirschfink, Ashley Frazer-Abel
Frontiers in Immunology
|
August 26, 2021
Expanding Horizons in Complement Analysis and Quality Control
Ashley Frazer-Abel, Michael Kirschfink, Zoltán Prohászka
Autoimmunity Reviews
|
June 19, 2008
Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?
Reinhard Schwartz-Albiez, Simon Laban, Stefan Eichmüller, et al.
Arthritis Care & Research
|
October 15, 2011
Remitting fever of unknown origin in a 20-year-old man
Marc Cinci, Michael Kirschfink, Hanns-Martin Lorenz, et al.
Artificial Organs
|
March 25, 2005
Impact of inverse plasma filtration on complement activation in porcine blood
Claudia Haltern, Michael Kirschfink, Rolf Rossaint, et al.
Immunobiology
|
August 1, 2016
Complement analysis 2016: Clinical indications, laboratory diagnostics and quality control
Zoltán Prohászka, Bo Nilsson, Ashley Frazer-Abel, et al.
Fertility and Sterility
|
April 1, 2014
Recurrent miscarriages, innate immunity, and autoimmune reaction to chlamydial 60-kDa heat shock protein--is there an association?
Waltraud Eggert-Kruse, Sandra Scholz, Michael Kirschfink, et al.
Targeted Oncology
|
November 15, 2014
Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack
Marc Cinci, Srinivas Mamidi, Wenhan Li, et al.
Molecular Oncology
|
March 12, 2013
Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab
Srinivas Mamidi, Marc Cinci, Max Hasmann, et al.
Page
of 10